|
|||||||||
|
February 4-6, 2010. Advances Against Aspergillosis 4th, Rome, Italy. The bi annual meeting of over 500 scientists, medical researchers, environmental investigators and clinicians was represented by U.S. researchers from Arizona, Maryland, Texas and New Jersey. Dr. Michael Gray, MD was invited to present a clinical case report involving Aspergillus terreus. Dr Gray with research associates Americans R. Shoemaker, D. Hooper, J. Dumanov-clinical research histopathologist, and G. Maulf reporting the pathology, diagnosis and treatment in a case originally diagnosed as a cancer. Researchers using diagnostic medical mycological, genomic and toxicological methods concluded that a sphenoid sinus mycoses was the result of chronic exposure to the A. terreus and other fungal pathogens. Interestingly there were were three other case reports involving A. terreus. The emergence of this highly select specie of fungi as an increasingly recognized pathogen is primarily due to genomic methods. This diagnosis could have only been achieved through the collaborative pathology, toxicology and highly integrated joint clinical research work and studies of the certified clinical industrial hygienist investigators. Keywords: allergy, asthma, diagnosis of fungal allergy, infectious mold, cancer, Immunoglobulin E sensitivity, IgE, mold, rhinitis, Aspergillus, Alternaria, Cladosporium, indoor allergens, contact dermatitis, Sc, subClincal investigations, CCIH |